Middle East News Dispatch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Dispatch.

Press releases published on June 8, 2026

Jun. 8, 2026

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 8, 2026

Fikra Ventures Appoints Mohamed Nabil as Prism56 Co-Founder & CTO and Moatassem Abdelhaleem as EIR

Indeterminate EIN Presswire

Jun. 8, 2026

إكس أس دوت كوم تختتم جولتها الناجحة في أمريكا اللاتينية بفعالية خاصة للعملاء والشركاء

Indeterminate EIN Presswire

Jun. 8, 2026

Nexera Technologies Announces Pricing of $1.2 Million Registered Direct Offering and Concurrent Private Placement

Indeterminate GlobeNewswire

Jun. 8, 2026

High-Grade Antimony Assays from Trenching on the South Zone on the Bald Hill Property Under Option from Globex

Indeterminate GlobeNewswire

Jun. 8, 2026

InnerGroup appoints Neha Bubna to accelerate AI-driven content production at InnerStudio

Indeterminate EIN Presswire

Jun. 8, 2026

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Indeterminate GlobeNewswire

Jun. 8, 2026

Polyrizon Makes Strong Clinical Progress: Secures Three U.S. Sites for NASARIX™ Trial

Indeterminate GlobeNewswire

Jun. 8, 2026

First-in-the-World Gene Therapy Delivers Missing Gene Directly to Infant's Brain, Marking Historic Milestone in Precision Medicine

Indeterminate GlobeNewswire

Jun. 8, 2026

Anortech Enters Carbon Capture Research Collaboration with the National Research Council of Canada

Indeterminate GlobeNewswire

Jun. 8, 2026

BOS Reports $7.1 Million Orders from India and US in the First Five Months of 2026

Indeterminate GlobeNewswire

Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire

Jun. 8, 2026

Cyabra Signs Agreement Valued at More Than $500,000 to Provide AI-Powered Narrative Intelligence and Disinformation Security Solutions to Leading International Research Institute

Indeterminate GlobeNewswire

Jun. 8, 2026

Auxite Introduces Multi-Metal Digital Ownership Infrastructure for Precious Metals

Indeterminate GlobeNewswire

Jun. 8, 2026

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire

Jun. 8, 2026

Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today

Indeterminate GlobeNewswire

Jun. 8, 2026

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire

Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 8, 2026

Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security

Indeterminate GlobeNewswire

Jun. 8, 2026

Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes

Indeterminate GlobeNewswire